A recent poll suggests that 49% of all Americans are planning to take a Covid vaccine when it is available. You are talking about 170 million doses of the vaccine that will be needed and double that if twice a year dosing is necessary. So, what will be the most important factor other than the discovery of an effective vaccine will be the efficient and expedient production of said vaccine. This is where NGIO comes into play. Cha Ching!
(6)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links